0000000000640317

AUTHOR

Magdalena C. Liebl

0000-0002-0685-7107

showing 3 related works from this author

The Role of p53 Signaling in Colorectal Cancer.

2021

Simple Summary The transcription factor p53 is a crucial tumor suppressor that regulates diverse cellular responses to protect against cancer development. Deactivating p53 signaling either by altering p53 regulators or by p53 mutations occurs frequently in human colorectal carcinoma (CRC). Forty-three percent of CRCs harbor p53 mutations that reduce wild-type p53 tumor suppressor activity and often provide neo-morphic functions, which contribute to tumorigenesis. In this review, we summarize wild-type p53 signaling, how it can be deregulated in CRC, and the functional and phenotypical effects of p53 mutations. We also discuss current therapeutic strategies of targeting p53. Abstract The tra…

0301 basic medicinewild type p53Cancer ResearchDNA repairCellular differentiationcolorectal cancerReview03 medical and health sciences0302 clinical medicinemedicineTranscription factorRC254-282gain-of-functionbiologyCell growthmutant p53CancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseUbiquitin ligasep53 signaling030104 developmental biologyOncology030220 oncology & carcinogenesisCancer cellbiology.proteinCancer researchMdm2cancer therapyp53 pathwayCancers
researchProduct

DAZAP2 acts as specifier of the p53 response to DNA damage.

2021

Abstract The DNA damage-responsive tumor suppressors p53 and HIPK2 are well established regulators of cell fate decision-making and regulate the cellular sensitivity to DNA-damaging drugs. Here, we identify Deleted in Azoospermia-associated protein 2 (DAZAP2), a small adaptor protein, as a novel regulator of HIPK2 and specifier of the DNA damage-induced p53 response. Knock-down or genetic deletion of DAZAP2 strongly potentiates cancer cell chemosensitivity both in cells and in vivo using a mouse tumour xenograft model. In unstressed cells, DAZAP2 stimulates HIPK2 polyubiquitination and degradation through interplay with the ubiquitin ligase SIAH1. Upon DNA damage, HIPK2 site-specifically ph…

DNA damageAcademicSubjects/SCI00010Ubiquitin-Protein LigasesRegulatorAntineoplastic AgentsCell fate determinationProtein Serine-Threonine Kinases03 medical and health sciencesMice0302 clinical medicineUbiquitinCell Line TumorGeneticsAnimalsPromoter Regions GeneticGeneMolecular BiologyCells Cultured030304 developmental biologyRegulation of gene expressionCell Nucleus0303 health sciencesbiologyNuclear ProteinsRNA-Binding ProteinsCell biologyUbiquitin ligaseGene Expression Regulation030220 oncology & carcinogenesisCancer cellbiology.proteinTumor Suppressor Protein p53Carrier ProteinsDNA DamageNucleic acids research
researchProduct

Cell fate regulation upon DNA damage : p53 Serine 46 kinases pave the cell death road

2019

Mild and massive DNA damage are differentially integrated into the cellular signaling networks and, in consequence, provoke different cell fate decisions. After mild damage, the tumor suppressor p53 directs the cellular response to cell cycle arrest, DNA repair, and cell survival, whereas upon severe damage, p53 drives the cell death response. One posttranslational modification of p53, phosphorylation at Serine 46, selectively occurs after severe DNA damage and is envisioned as a marker of the cell death response. However, the molecular mechanism of action of the p53 Ser46 phospho-isomer, the molecular timing of this phosphorylation event, and its activating effects on apoptosis and ferropt…

Programmed cell deathCell signalingCell cycle checkpointDNA RepairDNA repairDNA damage610 MedizinApoptosisCell fate determinationBiologyGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicine610 Medical sciencesAnimalsHumansPhosphorylation030304 developmental biology0303 health sciencesKinaseCell Cycle CheckpointsCell biologyPhosphorylationTumor Suppressor Protein p53030217 neurology & neurosurgeryDNA Damage
researchProduct